Cisplatin (CP) has been reported to activate murine macrophages to tum
oricidal state, however: its mechanism of action is not known. In the
present study it is reported that the production of: (a) interleukin-1
(IL-1); (b) tumor necrosis factor (TNF); (c) nitric oxide (NO); and (
d) macrophage-mediated cytotoxicity by cisplatin-treated bone marrow-d
erived macrophages were inhibited by PKC inhibitors H-7 and chelerythr
ine chloride. Also, it was observed that treatment of macrophages with
CP resulted in the translocation of PKC from the cytosol to the membr
ane fraction. These findings suggest the involvement of PKC in the act
ivation of bone marrow-derived macrophages with cisplatin. (C) 1998 El
sevier Science B.V. All rights reserved.